Licenses and licensing conditions may vary from country to country. Please always consult your country specific SPC or package leaflet.
In the regular course of business, Baxter interacts and communicates directly with consumers, patients, health-care professionals, employees and others. These audiences may share their personally identifiable information with Baxter which we collect, store and process electronically and/or manually. Please see the following Global Privacy Principles that govern Baxter´s use of personally identifiable information ("Private Information"). Since Baxter has many websites developed by Baxter business units and regions that can be accessed via the www.baxter.com site, please also see the information provided in the section entitled "Baxter´s Website Policies" below.
IMPORTANT: Baxter´s Global Privacy Statement states: "In all instances, Baxter believes that it is a person´s right to have their personal information kept private. Therefore, we have an obligation to implement privacy procedures and technical security measures to keep personal information private and secure." If you should have any questions concerning Baxter´s privacy practices or wish to access or correct Private Information that Baxter has collected from you, please submit an inquiry via Baxters on-line Privacy Inquiry Form, call: 1-800-422-9837 (847-948-4770) or fax your inquiry to 847-948-3642.
| Project | Research | Preclinical | Phase I | Phase II | Phase III | Licensed |
|
Immune Globulin Subcutaneous
(Human) 10% Primary immunodeficiencies (PID) |
||||||
| Immune Globulin Subcutaneous (Human) 10% with Recombinant Human Hyaluronidase (Phase II & III) Primary immunodeficiencies (PID) | ||||||
|
Immune Globulin Intravenous
(Human) 10% Multifocal motor neuropathy |
||||||
|
Immune Globulin Intravenous
(Human) 10% Mild to moderate alzheimer’s disease |
||||||
| High Concentration Immune Globulin Subcutaneous (Human) (Preclinical) | ||||||
| High Concentration Immune Globulin Subcutaneous (Human) with Recombinant Human Hyaluronidase (Preclinical) | ||||||
Baxter BioScience Grants Program
For more information on subcutaneous injection, please click here to view the video.